Heparin interference in anti-XA assays for rivaroxaban and apixaban

被引：0
|
作者：
Cutsforth, G. A. [1 ]
Finnegan, K. [2 ]
机构：
[1] Diagnostica Stago Inc, Vernon Hills, NJ USA
[2] SUNY Stony Brook, Stony Brook, NY 11794 USA
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2015年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PO117-WED
引用
收藏
页码：795 / 795
页数：1
相关论文
共 50 条
  • [31] The establishment and validation of efficient assays for anti-IIa and anti-Xa activities of heparin sodium and heparin calcium
    Suzuki, Takuo
    Ishii-Watabe, Akiko
    Hashii, Noritaka
    Nakagawa, Yukari
    Takahashi, Tomoko
    Ebisawa, Akiko
    Nishi, Seiichi
    Fujita, Naho
    Bando, Aya
    Sekimoto, Yuko
    Miyata, Kazuyoshi
    Endo, Toshio
    Otsu, Takuma
    Sugimoto, Shiori
    Kondou, Tadashi
    Fujita, Yuji
    Miyanaga, Naoyuki
    Mashimo, Masahiro
    Shimada, Norihiko
    Yoden, Hikaru
    Shimamura, Hideo
    Kurata, Yasunori
    Koyama, Sadatoshi
    Kawasaki, Nana
    BIOLOGICALS, 2013, 41 (06) : 415 - 423
  • [32] LABORATORY VALIDATION OF A CHROMOGENIC ANTI-XA ASSAY FOR APIXABAN
    Leger, Rachel R.
    Tange, Julie I.
    McBane, Robert D.
    Chen, Dong
    Pruthi, Rajiv K.
    AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (09) : E36 - E37
  • [33] Observed Apixaban Anti-Xa Levels in Obese Patients
    Harkness, Weston
    Pipitone, Olivia
    Joss, Jacqueline
    Schiedler, Michael
    Shagavah, Santon
    Moore, Ryan
    Hsing, Jeff
    ANNALS OF PHARMACOTHERAPY, 2022, 56 (11) : 1215 - 1221
  • [34] Anti-Xa activity in apixaban overdose: a case report
    Barton, James
    Wong, Anselm
    Graudins, Andis
    CLINICAL TOXICOLOGY, 2016, 54 (09) : 871 - 873
  • [35] Comparison of Commercial Low Molecular Weight Heparin and Homemade Anti-Xa Calibrators to a Commercial Specific Anti-Xa Calibrator for Plasma Rivaroxaban Quantification by Anti-Xa Oral Anticoagulant Plasma Concentration Chromogenic Assay
    Divsalar, Bita
    Kalantari, Tahereh
    Mohebbi, Soheila
    Bahmanimehr, Ardeshir
    Shahsavani, Amin
    Borhani-Haghighi, Afshin
    LABORATORY MEDICINE, 2023, 54 (04) : 400 - 405
  • [36] Acute Rivaroxaban Overdose Confirmed with Heparin Anti-Xa Activity and Serum Concentrations in an Adolescent Patient
    Ha, Catherine
    Howland, Mary Ann
    Su, Mark
    CLINICAL TOXICOLOGY, 2020, 58 (11) : 1229 - 1230
  • [37] Can an anti-Xa assay for unfractionated heparin be used to assess the presence of rivaroxaban in critical situations?
    Shin, Hyoshim
    Koh, Eun-Ha
    Lee, Gyeong-Won
    Song, Haa-Na
    Kim, Hyun-Young
    Park, Sungwoo
    JOURNAL OF VASCULAR SURGERY-VENOUS AND LYMPHATIC DISORDERS, 2020, 8 (05) : 741 - 747
  • [38] Validation of an assay for determination of anti-xa activity of Rivaroxaban
    Delavenne, X.
    Meuley, R.
    Baylot, D.
    Mismetti, P.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 965 - 966
  • [39] A universal anti-Xa assay for rivaroxaban, apixaban, and edoxaban measurements: method validation, diagnostic accuracy and external validation
    Willekens, Guido
    Studt, Jan-Dirk
    Mendez, Adriana
    Alberio, Lorenzo
    Fontana, Pierre
    Wuillemin, Walter A.
    Schmidt, Adrian
    Graf, Lukas
    Gerber, Bernhard
    Bovet, Cedric
    Sauter, Thomas C.
    Nagler, Michael
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 (06) : 1203 - 1212
  • [40] Accuracy of a single, heparin-calibrated anti-Xa assay for the measurement of rivaroxaban, apixaban, and edoxaban drug concentrations: prospective cross-sectional study
    Meihandoest, T.
    Studt, J. -D.
    Mendez, A.
    Alberio, L.
    Fontana, P.
    Wuillemin, W. A.
    Schmidt, A.
    Graf, L.
    Gerber, B.
    Amstutz, U.
    Bovet, C.
    Sauter, T. C.
    Nagler, M.
    SWISS MEDICAL WEEKLY, 2021, 151 : 7 - 8
12345